BEHAVIORAL TREATMENT OF RAYNAUD'S PHENOMENON
BEHAVIORAL TREATMENT OF RAYNAUD'S PHENOMENON
批准号:
2216664
负责人:
ROBERT R FREEDMAN
金额:
$20.69万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1983
资助国家:
美国
项目状态:
已结题
起止时间:
1983-09-01 至 1996-12-31
关键词:
Raynaud's disease alpha adrenergic receptor alpha antiadrenergic agent autogenic training behavioral medicine beta adrenergic receptor body temperature brain circulation cold temperature family genetics fingers gender difference gene mutation human subject human therapy evaluation injection /infusion linkage mapping magnetic resonance imaging norepinephrine plethysmography skin circulation vascular endothelium vasoconstriction vasodilation vasospasm
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We have recently demonstrated that the vasospastic attacks of Raynaud's
disease can be provoked despite digital nerve blockade and that local
cooling produces increases in alpha-adrenergic responsiveness not found
in normal volunteers. To more precisely determine the etiology of
primary Raynaud's disease, it is necessary to determine whether
abnormalities of alpha1 receptors, alpha2 receptors, or both are
necessary for the occurrence of a vasospastic attack. We propose to
examine this question by infusing intraarterially an alpha1 antagonist,
an alpha2 antagonist, and both antagonists while provoking attacks with
environmental and local cooling (Study 1). Since our investigations have
thus far utilized synthetic adrenergic drugs it is important to determine
the endogenous vasoconstrictive compound involved in Raynaud's attacks.
Since norepinephrine is highly potent at peripheral vascular
adrenoceptors, we propose to study its effects in cooled and uncooled
fingers of Raynaud's disease patients and controls (Study 2).
We have identified abnormalities of alpha-adrenergic receptors in
Raynaud's disease patients and have recently demonstrated familial
aggregation of this disorder. Since alpha-adrenergic receptors are under
genetic control, we propose to see if mutations of these genes are
involved in the occurrence of Raynaud's disease (Study 5).
We have shown that feedback-induced vasodilation is mediated in part by
a nonneural beta-adrenergic vasodilating mechanism and not through
changes in plasma catecholamines. A beta-adrenergic vasodilating
mechanism having the same time course as feedback-induced vasodilation
has recently been demonstrated on vascular endothelium. We propose to
determine the involvement of vascular endothelium in feedback-induced
vasodilation using a compound that specifically inhibits endothelium-
mediated vasodilation (Study 3).
Despite much research on temperature biofeedback, little has been done
on the brain mechanisms involved. A new MRI (magnetic resonance imaging)
method permits the noninvasive measurement of brain blood flow with
excellent spatial and temporal resolution. We propose to measure brain
blood flow by MRI before and after training in temperature feedback or
a credible control procedure (Study 4).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MOUSE MODEL OF MATERNAL IMMUNE ACTIVATION
-
批准号:8120340
-
项目类别:
-
资助金额:$17.5万
-
财政年份:2010
-
负责人:ROBERT R FREEDMAN
-
依托单位:
MOUSE MOLECULAR AND NEUROBIOLOGICAL MODELS
-
批准号:8120338
-
项目类别:
-
资助金额:$31.23万
-
财政年份:2010
-
负责人:ROBERT R FREEDMAN
-
依托单位:
ADMINISTRATION AND DATABASE
-
批准号:8120341
-
项目类别:
-
资助金额:$27.22万
-
财政年份:2010
-
负责人:ROBERT R FREEDMAN
-
依托单位:
STATISTICAL GENETICS AND TREATMENT ANALYSIS
-
批准号:8120342
-
项目类别:
-
资助金额:$9.52万
-
财政年份:2010
-
负责人:ROBERT R FREEDMAN
-
依托单位:
HUMAN CHRNA7 MODELS IN MICE
-
批准号:8120339
-
项目类别:
-
资助金额:$26.94万
-
财政年份:2010
-
负责人:ROBERT R FREEDMAN
-
依托单位:
NICOTINIC CHOLINERGIC RECEPTOR AGONISTS
-
批准号:8120343
-
项目类别:
-
资助金额:$11.89万
-
财政年份:2010
-
负责人:ROBERT R FREEDMAN
-
依托单位:
CHOLINERGIC TREATMENT OF SCHIZOPHRENIA
-
批准号:8120335
-
项目类别:
-
资助金额:$31.63万
-
财政年份:2010
-
负责人:ROBERT R FREEDMAN
-
依托单位:
REGULATION OF CHRNA7 EXPRESSION
-
批准号:8120337
-
项目类别:
-
资助金额:$24.48万
-
财政年份:2010
-
负责人:ROBERT R FREEDMAN
-
依托单位:
HUMAN PERINATAL INTERVENTION
-
批准号:8120336
-
项目类别:
-
资助金额:$26.75万
-
财政年份:2010
-
负责人:ROBERT R FREEDMAN
-
依托单位:
CHOLINERGIC TREATMENT OF SCHIZOPHRENIA
-
批准号:8515782
-
项目类别:
-
资助金额:$1.71万
-
财政年份:2009
-
负责人:ROBERT R FREEDMAN
-
依托单位:
REGULATION OF CHRNA7 EXPRESSION
-
批准号:7752182
-
项目类别:
-
资助金额:$25.4万
-
财政年份:2009
-
负责人:ROBERT R FREEDMAN
-
依托单位:
STATISTICAL GENETICS AND TREATMENT ANALYSIS
-
批准号:7752199
-
项目类别:
-
资助金额:$9.42万
-
财政年份:2009
-
负责人:ROBERT R FREEDMAN
-
依托单位:
ADMINISTRATION AND DATABASE
-
批准号:7752198
-
项目类别:
-
资助金额:$27.45万
-
财政年份:2009
-
负责人:ROBERT R FREEDMAN
-
依托单位:
HUMAN CHRNA7 MODELS IN MICE
-
批准号:7752195
-
项目类别:
-
资助金额:$28.04万
-
财政年份:2009
-
负责人:ROBERT R FREEDMAN
-
依托单位:
HUMAN PERINATAL INTERVENTION
-
批准号:7752181
-
项目类别:
-
资助金额:$27.79万
-
财政年份:2009
-
负责人:ROBERT R FREEDMAN
-
依托单位:
MOUSE MOLECULAR AND NEUROBIOLOGICAL MODELS
-
批准号:7752190
-
项目类别:
-
资助金额:$32.27万
-
财政年份:2009
-
负责人:ROBERT R FREEDMAN
-
依托单位:
NICOTINIC CHOLINERGIC RECEPTOR AGONISTS
-
批准号:7752204
-
项目类别:
-
资助金额:$13.06万
-
财政年份:2009
-
负责人:ROBERT R FREEDMAN
-
依托单位:
MOUSE MODEL OF MATERNAL IMMUNE ACTIVATION
-
批准号:7752197
-
项目类别:
-
资助金额:$17.41万
-
财政年份:2009
-
负责人:ROBERT R FREEDMAN
-
依托单位:
CHOLINERGIC TREATMENT OF SCHIZOPHRENIA
-
批准号:7752180
-
项目类别:
-
资助金额:$29.4万
-
财政年份:2009
-
负责人:ROBERT R FREEDMAN
-
依托单位:
MENOPAUSAL HOT FLASHES
-
批准号:7349398
-
项目类别:
-
资助金额:$2.72万
-
财政年份:2006
-
负责人:ROBERT R FREEDMAN
-
依托单位:
海外基金